Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Measles Companies

Measles is a highly contagious viral infection caused by the measles virus (MeV). Vaccination is the primary preventive measure against measles, and several companies are involved in the production and development of measles vaccines.

Measles Key Companies Latest Measles Companies Update

November 2023: Indian Immunologicals (IIL) has introduced the Mabella measles and rubella vaccination for children. Mabella, a live-attenuated MR vaccine developed in collaboration with the Polyvac Institute of Vietnam, was released as part of the 25th anniversary celebrations of the IIL division Human Biologicals Institute (HBI) in India. Extensive human clinical studies have shown that the vaccination is both safe and efficacious. The event highlights the critical need for measles and rubella control, which kill over one lakh children worldwide. The vaccine producer stated in a press on the activities of the division that was created in 1998 that HBI had indigenously produced the country's "first safe vero-cell rabies vaccine Abhayrab [thus] paving the way for the government of India to phase out the painful nerve tissue vaccine."

April 2023: South Sudan's Ministry of Health, in collaboration with Gavi, the Vaccine Alliance, UNICEF, WHO, and other important partners, has initiated a statewide measles vaccination campaign in April 2023. More than 2.7 million youngsters aged 6-59 months will be vaccinated against the highly contagious illness as part of the program. South Sudan's perseverance in carrying out immunization campaigns, despite conflicting health priorities such as recovery from the COVID-19 epidemic, is highlighted by the beginning of the measles vaccine campaign. Measles is a highly contagious virus-borne illness that occurs periodically in endemic locations. Measles can cause significant consequences in malnourished children and immunocompromised individuals, including blindness, encephalitis, severe diarrhea, ear infection, and pneumonia.List of Measles Key companies in the market

Astellas Pharma Inc. (Japan)

Emergent BioSolutions Inc. (US)

Abbott (US)

Biomedical Diagnostics (US)

Serum Institute of India Pvt. Ltd. (India)

Sanofi (US)

Novartis AG (Switzerland)

Johnson & Johnson Services, Inc. (US)

MedImmune (US)

CSL Limited (Australia)

GlaxoSmithKline plc (US)

Bavarian Nordic (Denmark)

Merck & Co., Inc. (US)

Measles Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.